Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial CK-MBmass

Heart

Volumn 85, Issue 2, 2001, Pages 143-148

  Bholasingh, R ^a   De Winter, R J ^a   Fischer, J C ^a   Koster, R W ^a   Peters, R J G ^a   Sanders, G T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac emergency room; Creatine kinase MB; Length of stay; Myocardial infarction

Indexed keywords

CREATINE KINASE MB;

ADULT; AGED; ARTICLE; CLINICAL PATHWAY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EMERGENCY WARD; ENZYME ASSAY; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAFETY; THORAX PAIN;

EID: 0034758323     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.2.143     Document Type: Article

References (38)

1. A computer protocol to predict myocardial infarction in emergency department patients with chest pain
2. A proposed strategy for utilization of creatine kinase-MB and troponin I in the evaluation of acute chest pain
3. Diagnostic marker cooperative study for the diagnosis of myocardial infarction
4. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room
5. Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain
6. Diagnostic accuracy of myoglobin concentration for the early diagnosis of acute myocardial infarction
7. Serial creatinine kinase (CK) MB testing during the emergency department evaluation of chest pain: Utility of a 2-hour delta CK-MB of +1.6 ng/ml
8. Ruling out acute myocardial infarction early with two serial creatine kinase-MBmass determinations
9. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
10. Early diagnosis of acute myocardial infarction by CK-MB mass measurements
11. Multicenter study of creatine kinase-MB use: Effect on chest pain clinical decision making
12. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB
13. Critical difference between serial measurements of CK-MB mass to detect myocardial damage
14. Determination of creatine kinase isoenzyme MB (CK-MB): Comparison of methods and clinical evaluation
15. Immunochemical determination of LD-1 and LD-2 in CK-MB fraction of column eluates
16. Biological variation of cardiac markers: Analytical and clinical considerations
17. Ruling out acute myocardial infarction. A prospective multicenter validation of a 12-hour strategy for patients at low risk
18. Feasibility of a rapid diagnostic protocol for an emergency department chest pain unit
19. Acute chest pain in the emergency room. Identification and examination of low-risk patients
20. An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: Results of a randomized study (ROMIO)
21. Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain
22. A rapid diagnostic and treatment center for patients with chest pain in the emergency department
23. Use of troponin T and creatine kinase-MB subunit levels for risk stratification of emergency department patients with possible myocardial ischemia
24. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: A report from a National Heart Attack Alert Program Working Group
25. Test of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) for prehospital use
26. Comprehensive strategy for the evaluation and triage of the chest pain patient
27. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: Executive summary of a National Heart Attack Alert Program Working Group Report
28. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases
29. IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and project presentation
30. Rapid enzyme diagnosis of patients with acute chest pain reduces patient stay in the coronary care unit
31. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain
32. The costs and effectiveness of a rapid diagnostic and treatment protocol for myocardial infarction
33. Financial impact of a rapid CK-MB-specific immunoassay on the diagnosis of myocardial infarction
34. Value of additional two-hour myoglobin for the diagnosis of myocardial infarction in the emergency department
35. Myoglobinuria, hemoglobinuria, and acute renal failure
36. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients
37. Missed diagnoses of acute cardiac ischemia in the emergency department